Van den Berg-Loonen PM - Search Results

1

Prevention of primary HLA class I allo-immunization with leucocyte-poor blood components produced without the use of platelet filters.

Ten Haaft MA, Van den Berg-Loonen PM, Van Rhenen DJ. Ten Haaft MA, et al. Vox Sang. 1992;63(4):257-61. doi: 10.1111/j.1423-0410.1992.tb01231.x. Vox Sang. 1992. PMID: 1481473

2

The influence of DR match of blood donor and recipient on the formation of T- and B-cell antibodies and on renal allograft outcome.

van Hooff JP, van den Berg-Loonen PM. van Hooff JP, et al. Among authors: van den berg loonen pm. Transpl Int. 1992;5 Suppl 1:S599-600. doi: 10.1007/978-3-642-77423-2_175. Transpl Int. 1992. PMID: 14621886

3

The impact of ischemic lesions in the donor kidney, donor age, recipient age and HLA (A, B, C, DR, DQ) matching on clinical course after kidney grafting.

Christiaans MH, Peltenburg HG, Niemann FH, Kootstra G, Lavrijssen AT, van den Berg-Loonen PM, Tiebosch A, Leunissen KM, van Hooff JP. Christiaans MH, et al. Among authors: van den berg loonen pm. Transpl Int. 1992;5 Suppl 1:S627-8. doi: 10.1007/978-3-642-77423-2_184. Transpl Int. 1992. PMID: 14621893

4

Very low frequency of rejection due to HLA-(A+)B+DQ matching.

Christiaans MH, van den Berg-Loonen PM, Nieman FH, van Hooff JP. Christiaans MH, et al. Among authors: van den berg loonen pm. Transplant Proc. 1992 Dec;24(6):2441-2. Transplant Proc. 1992. PMID: 1465822 No abstract available.

5

B cell antibodies after planned transfusions.

van den Berg-Loonen PM, Leunissen KM, Kootstra G, van Hooff JP. van den Berg-Loonen PM, et al. Transplant Proc. 1987 Feb;19(1 Pt 1):743. Transplant Proc. 1987. PMID: 3274860 No abstract available.

6

Risk factors for cytomegalovirus infection and disease in renal transplant recipients: HLA-DR7 and triple therapy.

Kraat YJ, Christiaans MH, Nieman FH, van den Berg-Loonen PM, van Hooff JP, Bruggeman CA. Kraat YJ, et al. Among authors: van den berg loonen pm. Transpl Int. 1994 Aug;7(5):362-7. doi: 10.1007/BF00336713. Transpl Int. 1994. PMID: 7993574

7

More favorable clinical course in kidney allograft recipients due to HLA-B+ DR matching.

Christiaans MH, van den Berg-Loonen PM, Peltenburg HG, Leunissen KM, van Hooff JP. Christiaans MH, et al. Transplant Proc. 1991 Oct;23(5):2674. Transplant Proc. 1991. PMID: 1926529 Clinical Trial. No abstract available.

8

Cadaveric kidney exchange on the basis of HLA-matching is already cost-effective in the first year after grafting.

Christiaans MH, van den Berg-Loonen PM, Nieman FH, Cohen B, Kootstra G, van Hooff JP. Christiaans MH, et al. Among authors: van den berg loonen pm. Transplant Proc. 1993 Feb;25(1 Pt 2):1685-6. Transplant Proc. 1993. PMID: 8442236 No abstract available.

9

Clinical significance of flow cytometry before and after renal transplantation.

van Hooff JP, Christiaans MH, van den Berg-Loonen PM. van Hooff JP, et al. Among authors: van den berg loonen pm. Transplant Proc. 1999 Dec;31(8):3352. doi: 10.1016/s0041-1345(99)00822-2. Transplant Proc. 1999. PMID: 10616503 No abstract available.

10

Blood eosinophilia and renal allograft rejection.

Frenken LA, Leunissen KM, van den Berg-Loonen PM, Kootstra G, van Hooff JP. Frenken LA, et al. Transplant Proc. 1987 Feb;19(1 Pt 2):1584-5. Transplant Proc. 1987. PMID: 3079028 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

23 results

Search Page